Use of the Sentinel Node Biopsy for Early Endometrial Cancer. — SNE  

Cancer of Endometrium Clinical Trial

Official title: Evaluation (Good Medical Practice Evaluation) of the Use of the Sentinel Node Biopsy in Early Stage Endometrial Cancer and Its Implication on the Adjuvant Treatement and on the Outcomes of the Cancer

Status Recruiting

Clinical Trial Summary

This is an obstervationnal study, to evaluate the good clinical practice of the use of the sentinel node biospy in early stage endometrial cancer. The collaborating centres with the OncoGynecology board of the King Albert II Institute of the Clinique Universitaire Saint-Luc will also particpate to the trial.

Sentinel node biospy is not yet validated for endometrial cancer, even if lots of leading team in the world published very good result and that the first prospectives trials are already published with also excellents results. The investigators decided then to include this practice in their institutional guideslines and also to registred the procedure.

Clinical Trial Description

All the sentinel node biopsy procedures for endometrial cancer will be record online via the REDCap tools, securized on a servor in Saint-Luc. Automatic email for the following of the patients and the post operative event will be send regularly for every patient to the physicians who include the patient. Efficacy of the technique, False negative and postive rate, modifications of the adjuvant treatement, long terme evolution and complication wil be evaluate. ;

Related Conditions & MeSH terms

• Cancer of Endometrium
• Endometrial Neoplasms

• NCT number: NCT02545348
• Study type: Observational
• Source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Contact: Mathieu LUYCKX
• Phone: 27649509
• Email: mathieu.luyckx@uclouvain.be
• Status: Recruiting
• Start date: August 2015
• Completion date: September 2020